Japan Healthcare Venture Summit Stage

Open Innovation Session Japanese Session

Time/Date: October 11.(Wed.), 2017 14:00-16:00
Venue: Pacifico Yokohama Exhibition Hall

Verification and Outlook of Drug Discovery Open Innovation Models

We will present distinctive open innovation models and, by veri fying the practical effectiveness of each model and discussing its future outlook, we will provide the foundations for the creation and operation of an effective model.

Coordinator President & CEO, FORESIGHT & LINX K.K.
Takato NOUMI

Senior Fellow, Shionogi & Co., Ltd. /
Visiting Professor, Cybermedia Center, Osaka University
Tsuneaki SAKATA

Head of Open Innovation Center Japan,
Bayer Yakuhin K.K.
Shunichi TAKAHASHI

Astellas AK Project Leader, Astellas Pharma Inc.
Ichiro ARAMORI

Head of Japan Research, Asia-Pacific R&D, Sanofi Jeffrey Encinas
Director, External Innovation Japan, Eli Lilly Japan K.K.
Takao HONDA

Kobe Pharma Research Institute,
Nippon Boehringer Ingelheim Co., Ltd.
Shinobu SUZUKI

 

Pitch Session Japanese Session

Venue: Pacifico Yokohama Exhibition Hall

Presentations by Venture Companies Seeking to Commercialize Pharmaceuticals, Medical Device s, Regenerative Medicine Products, etc. and Sessions for Exchanging Opinions with Advisers

Mdicinal Science

Time/Date: October 12.(Thu.), 2017 10:45-11:45

Young Venture Session

Time/Date: October 12.(Thu.), 2017 13:30-14:30

Medical Devices

Time/Date: October 12.(Thu.), 2017 15:30-16:30

Regeneration Medicine

Time/Date: October 13.(Fri.), 2017 10:15-11:15

Return
Top